Navigation Links
Alimera Sciences Reports Fourth Quarter 2012 Financial Results
Date:3/21/2013

ttee at NICE is expected to assess the impact of the ILUVIEN PAS on ILUVIEN's cost effectiveness and determine whether an update to the recently published final guidance is warranted.

"The interaction with NICE is proceeding as we expected and we believe that the ILUVIEN PAS could result in a change in NICE guidance," said Mr. Myers. "In both Germany and the UK we have added experienced resources to address market access challenges that other ophthalmology companies have similarly had to navigate."

FDA UpdateAlimera intends to resubmit its New Drug Application for ILUVIEN to the U.S. Food and Drug Administration (FDA) by the end of March.  Using data from Alimera's two previously completed pivotal Phase III clinical trials (FAME™ Study), the resubmission will focus on the safety aspects of ILUVIEN and the population of patients with chronic DME, the same group for which marketing approval for ILUVIEN has been granted in various EU countries.  Alimera will communicate any new PDUFA date once it is known.

Fourth Quarter 2012 Financial Results Research and development expenses for the fourth quarter of 2012 increased to $2.3 million, compared to $1.4 million for the fourth quarter of 2011. The increase was primarily attributable to the preparation of the resubmission of the NDA for ILUVIEN with the U.S. FDA expected in the first quarter of 2013.

For the full year ended December 31, 2012, research and development expenses increased to $7.9 million, compared to $7.1 million for the full year 2011.

General and administrative expenses in the fourth quarter of 2012 were $2.1 million, compared to $1.4 million in the fourth quarter of 2011. The increase was primarily attributable to infrastructure build in Europe in preparation for the launch of ILUVIEN in 2013. 

Marketing expenses in the fourth quarter of 2012 were $3.8 million, compared to $3.1
'/>"/>

SOURCE Alimera Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alimera Sciences To Release Fourth Quarter And Fiscal Year 2012 Financial Results
2. Alimera Sciences Participating in Credit Suisse London One-on-One Healthcare Conference
3. Alimera Sciences Names European Management Team
4. Alimera Sciences To Present At Credit Suisse 2012 Healthcare Conference
5. Alimera Sciences To Present At 2012 Stifel Nicolaus Healthcare Conference
6. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2012 Annual Report
7. BioDelivery Sciences to Present at the 25th Annual ROTH Conference
8. Industry Veteran Katrine Bosley Joins Genocea Biosciences Board Of Directors
9. Pressure BioSciences, Inc. to Present at the SeeThruEquity Spring Investor Microcap Forum
10. Neurocrine Biosciences To Present At The 25th Annual Roth Conference
11. PointCross Life Sciences SENDBox and SEND-as-a-Service Prepare Pharma Companies to Comply with the FDAs Upcoming e-Data Submission Mandate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... WOONSOCKET, R.I. , Aug. 28, 2014  In ... of developing health complications from the flu, pneumonia, ... MinuteClinic ® have declared September to be ... as they age, it is important that adults ... date on their vaccinations. CVS pharmacists and MinuteClinic ...
(Date:8/28/2014)... ROCK, Colo. , Aug. 28, 2014   ... diagnostic company focused on obtaining FDA clearance for and ... rapid blood test for aiding in identifying children, adolescent, ... are at low risk for appendicitis, today announced it ... & Renshaw 16 th Annual Global Investment Conference ...
(Date:8/28/2014)... 28, 2014  Stryker Orthopaedics, the Official Joint Replacement Products ... message of joint health to golf fans at the next ... Deutsche Bank Championship. The company,s fan destination – "The Stryker ... on 9" at the TPC Boston in Norton, ...    At the Deutsche Bank Championship, Stryker will ...
Breaking Medicine Technology:September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Venaxis to Present at September Investor Conferences 2Venaxis to Present at September Investor Conferences 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 2Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 3Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 4Stryker, Official Joint Replacement Products Of The PGA TOUR, Heads To Boston For The Deutsche Bank Championship 5
... Aug. 3, 2011 Reportlinker.com ... research report is available in ... Canada Orthopedic Devices Market Outlook ... Spinal Surgery, Orthobiologics, Trauma Fixation ...
... 2011 Grifols, a global healthcare company and ... the structure of its new North American Commercial ... U.S. commercial group will be organized by product ... North America.  The Canadian organization, a major presence ...
Cached Medicine Technology:Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 2Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 3Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 4Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 5Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 6Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 7Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 8Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 9Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 10Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 11Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 12Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 13Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 14Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 15Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 16Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 17Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 18Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 19Canada Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others 20Grifols Announces New North American Commercial Operations Organization 2Grifols Announces New North American Commercial Operations Organization 3
(Date:8/28/2014)... A fortuitous collaboration at Rice University has led ... natural antibiotic. , The laboratory recreation of a ... the fight against bacteria that evolve resistance to ... , As part of the process, Rice ... Shamoo and their colleagues created and tested a ...
(Date:8/28/2014)... nerves with adhesives, most researchers place glue directly on ... the nerve ends well and allows glue to easily ... However, it is difficult to insert the nerve ends ... there is frictional resistance. Xiangdang Liang and co-workers from ... conduit for the adhesive technique and defined the best ...
(Date:8/28/2014)... can be treated with nasal septum cells. Researchers at ... that cells taken from the nasal septum are able ... and can thus repair articular cartilage defects. The nasal ... joint environment is associated with the expression of so-called ... has published the research results together with the ...
(Date:8/28/2014)... every 200 Ontarians has been diagnosed with inflammatory bowel ... the disease increasing by 64 per cent between 1999 ... the Institute for Clinical Evaluative Sciences (ICES), the Children,s ... Research Institute. That puts Ontario in the 90th percentile ... published this week in Inflammatory Bowel Diseases , ...
(Date:8/28/2014)... seven per cent of rheumatoid arthritis patients in the ... as anti-TNF therapies did not take them as prescribed ... Infirmary were among those from 60 hospitals around the ... Arthritis Research UK Centre for Genetics and Genomics at ... that failure to take the drugs correctly, known as ...
Breaking Medicine News(10 mins):Health News:Synthesis produces new antibiotic 2Health News:Synthesis produces new antibiotic 3Health News:Synthesis produces new antibiotic 4Health News:From nose to knee: Engineered cartilage regenerates joints 2Health News:Ontario has one of the highest rates of IBD in the world 2Health News:Arthritis patients failing to take expensive medication, according to new research 2
... the malaria parasites to attack the red blood cells. ... Cell, will help the scientists in designing vaccines against ... through which malaria parasites invade red blood cells is ... merozoites called EBA-175 to a receptor protein on the ...
... a smart bomb for cancer treatment is to be reported ... into the tumor, seal the opening and then deliver ... This will leave the healthy cells unharmed. ,The ... cancer have the potential of being a revolutionary form of ...
... those people suffering from tension-headaches, acupuncture may be the ... journal BMJ said that acupuncture can reduce the incidence ... - the gold standard of clinical trials - researchers ... of tension headache into three groups. ,Over ...
... delays healing of physical wounds, a new study says//. ... of Illinois at Chicago in a study of laboratory ... delayed the closing of wounds by more than 45 ... of cell and genetic changes accounted for the slow ...
... and happen even when people are not aware of their ... 2005 issue of Nature. ,Researchers from University of California, ... Affairs Health System had undertaken the study to find out ... when they are actually not aware of doing so. ...
... A new study by scientists in Japan may help ... UPI. ,Richard Smith, a research professor in otolaryngology ... University gave a genetically deafened mouse interfering RNA (Ribonucleic ... that would otherwise cause deafness. ,"By preventing its ...
Cached Medicine News:Health News:Researchers Discover Protein That Causes Malaria 2Health News:An Anti-cancer Smart Bomb delivered using a Nanocell 2Health News:An Anti-cancer Smart Bomb delivered using a Nanocell 3Health News:Acupuncture May Be An Effective Treatment Against Tension-Headaches 2Health News:Habit Memory May Enhance Learning In People 2
... products for autoimmune testing feature single-well ANA ... as specific reflex tests including dsDNA, and ... (Ro), SS-B (La), Scl-70 and Jo-1. In ... full line of products for Cardiolipins (IgA, ...
... Our ELISA products for autoimmune testing feature ... as well as specific reflex tests including ... Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 and ... includes a full line of products for ...
... products for autoimmune testing feature single-well ANA ... as specific reflex tests including dsDNA, and ... (Ro), SS-B (La), Scl-70 and Jo-1. In ... full line of products for Cardiolipins (IgA, ...
... is a leading provider of immunofluorescence assays, ... menu that includes kits for autoimmune diseases, ... miscellaneous conjugates and components. Our Impact IFA ... of substrates and kit sizes to choose ...
Medicine Products: